Related Experiment Video
Updated: Sep 5, 2025
08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
690
Early and Aggressive Treatment May Modify Anti-Hu Associated Encephalitis Prognosis.
Perrine Marion1, Aliénor De Chalus1, Laetitia Giorgi1
1Pediatric Neurology Department, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Le Kremlin Bicêtre, France.
Neuropediatrics
|July 11, 2022
Summary
This study reports a rare pediatric case of anti-Hu encephalitis, a severe neurological condition. Early diagnosis and aggressive immunotherapy led to significant recovery in a 4-year-old child with ganglioneuroblastoma.
Area of Science:
- Neurology
- Pediatric Oncology
- Immunology
Background:
- Anti-Hu encephalitis is a rare paraneoplastic syndrome typically seen in adults.
- Pediatric cases are infrequent, often lack identifiable tumors, and usually have severe outcomes.
Observation:
- A 4-year-old girl presented with cerebellar syndrome and behavioral changes.
- Brain MRI revealed bilateral lesions; autoimmune assessment confirmed positive anti-Hu antibodies.
- A ganglioneuroblastoma was diagnosed via CT scan.
Findings:
- The child underwent surgical tumor removal and aggressive immunotherapy (dexamethasone, rituximab, IVIg).
- Significant neurological improvement was observed within 9 months, allowing the child to return to school.
- Early diagnosis and prompt, specific immunotherapy were crucial for recovery.
Implications:
- This case highlights the possibility of severe neurological conditions like anti-Hu encephalitis in children.
- It underscores the importance of early diagnosis and aggressive immunotherapy for favorable outcomes in pediatric paraneoplastic syndromes.
- The successful treatment suggests potential therapeutic strategies for similar rare pediatric neurological disorders.
